7OPAM50MET: A prognostic model based on PAM50 and clinical variables in metastatic hormone receptor (HR)-positive/HER2 negative breast cancer
Prat, A, Tsai, Y-H, Pascual, T, Paré, L, Vidal, M, Adamo, B, Brase, J C, Johnston, S R D, Ciruelos, E M, Parker, J SVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz095.006
Date:
May, 2019
File:
PDF, 79 KB
2019